Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.
An article published in The New York Times covers the exciting story about the groundbreaking oral treatment for gonorrhea, Zoliflodacin, acing its phase 3 clinical trials. The nonprofit, GARDP, developed the antibiotic in collaboration with an American pharmaceutical company called Innoviva Specialty Therapeutics. The nonprofit sponsored the Phase 3 trial of the drug. In exchange, it holds […]
Read moreRead more Read More